Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) concluded the trading at $700.33 on on Friday, February 21 with a rise of 0.62% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 18.29. Considering stock’s 52-week price range provides that REGN hit
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) price on Friday, February 07, fall -1.67% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $710.00. A look at the stock’s price movement, the close in the last trading session was $722.07, moving
In the biotechnology industry, companies produce drugs that treat illness and diagnostic technologies. For these products to be approved by the FDA, the process is lengthy and expensive. Food and Drug Administration (FDA). In this case, investors may have to wait years to find out
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
